Leaflet REDERGIN 0.3mg / ml solution for injection
Product code: W01423001 Quantity: 50
Indicated for: cognitive disorders; cerebral circulatory disorders
Route of administration: injectable
Substance: codergocrine (alkaloid derivative)
ATC: C04AE01 (Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids)
Codergocrine is an ergot derivative used for the treatment of cerebral and peripheral circulatory disorders. It works by improving blood flow and reducing vascular resistance, helping to alleviate associated symptoms.
The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.
Patients should be aware of potential side effects, such as nausea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, dizziness, and headaches. In rare cases, severe reactions such as vasospasm or allergic reactions may occur. Patients should be informed of these risks before use.
General data about REDERGIN 0.3mg / ml
- Substance: codergocrine
- Date of latest medicines list: 01-07-2013
- Product code: W01423001
- Concentration: 0.3mg / ml
- Pharmaceutical form: solution for injection
- Quantity: 50
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for codergocrine
Concentrations available for codergocrine
- 0.1%
- 0.3mg/ml
- 1mg/ml